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Abstract
The topic of this thesis focus on how statistical methods for analyzing Genome
Wide Association data can be improved, particularly in the case of Coeliac Dis-
ease (gluten intolerance). The key idea is that in complex diseases where sev-
eral genes are involved, the power of detecting new genetic risk variants can be
improved by considering several genes in the same model.
A genetic variant in the HLA region on chromosome 6 is necessary but not
sufficient to develop Coeliac Disease. We use this knowledge to illustrate that
among healthy individuals, the distribution of other genetic risk variants will
depend on if they have the necessary variant or not. In Paper I we propose a
method which use the Cochran Armitage test to test for a trend in allele fre-
quencies. Simulations are used to evaluate the power of this test compared with
the commonly used Pearson 1 df chisquare test and the test is then applied to a
previously published Coeliac Disease case-control material.
Genotype imputation can be used to increase the sample size in Genome
Wide Association studies, especially when several studies with different sets of
markers are combined. In Paper II we use imputation to increase the sample size
at markers which was only genotyped in part of the sample in a Coeliac Disease
family material. A version of the TDT in which the imputation probabilities are
used, is applied to these data. In addition a likelihood ratio test searching for
two-locus interactions by comparing the heterogeneity and epistasis models is
applied to the same material.
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Part I
INTRODUCTION

Chapter 1
Introduction
Genetic association studies aim to identify genetic variants that vary between
individuals with different disease states (affected/unaffected). In this chapter
we will give the genetic background to the subject.
1.1 Background
The DNA is built up by different arrangements of the four nucleotides adenine
(A), cytosine (C), guanine (G) and thymine (T). The DNA molecule has the
shape of a double helix where each nucleotide pairs up with its complementary
nucleotide - A binds to T and C binds to G, and the DNA is tightly packed
into chromosomes. The human genome consist of 23 pairs of chromosomes,
22 pairs of autosomes - all chromosomes which are present in two copies in
both males and females - and one pair of sex chromosomes, females have two
X chromosomes and males have one X and one Y chromosome. In each pair
of chromosomes, one of the chromosomes is inherited from the mother and the
other from the father. Many traits are passed from generation to generation,
the units that transmit these traits from parent to offspring are called genes,
each gene consists of a sequence of DNA which influence some function in
the organism. Diploid organisms (like humans) have two copies of each gene
3
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- one on each of the two chromosomes of the same type - which they inherit
from their parents. An allele contain genetic information at a certain locus on
the parental chromosome. Each gene occupy a certain position (locus) on the
chromosome, and the parent randomly pass on one of the two alleles of each
gene to its offspring. At each locus in the genome which include population
variation, i.e. the alleles are different, there are several possible genotypes -
combinations of alleles on the same locus of two homologous chromosomes.
A genotype is heterozygous if the two alleles are different, and homozygous if
they are equal. A phenotype is the physical expression of a genotype, e.g. an
individual’s eye colour.
1.1.1 Cell Division, genetic maps and linked genes
During reproduction, the cell divides in new cells through meiosis in two dif-
ferent stages. During meiosis I the homologous chromosomes are separated in
two new cells, each cell contains one of each chromosome. In meiosis II the
two chromatides of each chromosome are separated in two new haploid cells.
A haploid cell contains only one of each chromosome. During meiosis I chro-
matides will cross over each other, both chromatides will break at the same
positions and the broken piece will join the other chromatide. This event oc-
curs randomly and sometimes several times on each chromosome. The result of
this will be an alternating sequence with pieces from both of these chromatides,
which creates genetic variation. The probability of a cross-over will increase
with increased distance between the loci. In some regions of the genome the
intensity for crossovers are higher than in other regions. A genetic map con-
tains information about the frequency of cross-overs across the entire genome.
To measure the intensity of cross-overs between two loci in the genome we use
genetic distance Morgan (M), where 1 M corresponds to an expected number
of 1 cross-over between two loci.
Two genes are said to be linked together if it is rare with recombination
between these two, these two will then in most situations be passed together
from parent to offspring.
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1.2 Coeliac Disease
Coeliac disease (CD) is a common, complex and life-long disease. It is autoim-
mune and unique in the way that the environmental factor is precisely known.
The prevalence of CD is about 1-3 % in the caucasian population [1]. Individ-
uals having the disease get an inflammation in the small intestine from a diet
containing gluten. Gluten is a protein derived from wheat, barley and rye. CD
was previously believed to be a malabsorption syndrome among children, but
now it is known that it can be diagnosed at any age. It affects many internal or-
gans and it is associated with several other diseases such as Down’s syndrome,
Turner’s syndrome and Type I Diabetes. The only available therapy is a gluten-
free diet, but up to 30 % of the patients still get symptoms [2].
This disorder show a strong association to the Human Leutocyte Antigen
(HLA) class II region on chromosome 6. About 90% of celiac patients carries
alleles that code for the HLA-DQ2 protein, and most of the remaining cases
carry the HLA-DQ8 instead. These variants are however present in 25-30 %
of the caucasian population, hence these genes are necessary but not sufficient.
Twin studies suggest that the contribution of the HLA genes to the total genetic
component of CD is less than 50 % [3]. This altogether indicates that there are
more genes needed to be affected by CD. In the present search for genes which
increase the risk of CD, there are several regions in the human genome which
have shown association to CD, but these genes have not yet been verified.
It is quite possible that there is interaction between different genes (epista-
sis) and rather likely that there is heterogeneity (or phenocopies).
Gluten proteins are digested by enzymes into aminoacids and peptides,
gliadin peptides damages the epithelial cells and the increased permeability
enables them to get into the lamina propria, where the peptides interact with
HLA-DQ2 (or HLA-DQ8), inducing production of cytokines which will dam-
age the tissue.
The sympthoms of the disease vary a lot between individuals. Among adults
the disease is more common among women than men, similarly to other autoim-
mune disorders, but this is not the case for individuals older than 65 years. The
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heterogeneity in symptoms makes it difficult to diagnose/detect cases and there
are many ’silent cases’ which sometimes are wrongly diagnosed, but the rate of
diagnosed cases is increasing.
The diagnosis includes a Duodenal Biopsy and a gluten-free diet. The
biopsy often needs to be performed at least 4-6 times, and since it is a unpleas-
ant method of diagnosis, other methods would be preferable for this expensive
and socially inconvenient disorder.
Chapter 2
Genome Wide Association
Studies
2.1 Genome Wide Association
The genome contains approximately 3 billions of base pairs. Most of the genome
is identical for all humans, but about 0.1 % varies between different individuals.
It is these variations that influence many of our variable traits such as height and
eye colour. With this genetic knowledge comes also an urge to explain the bio-
logical mechanisms behind diseases and other traits which seem to be inherited
from parent to offspring.
By identifying the genetic variants which affect the risk of a certain disease
it might be possible to diagnose cases at an earlier stage of the disease, and
patients can start treatment before the disease is severe. Since not all patients are
helped by the same kind of treatment, it would be desirable to choose treatment
based on genetic tests. In this way patients could start the appropriate treatment
earlier, without having to try out treatments which are inefficient for them.
7
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2.1.1 We inherit our parents traits
Many of our traits are inherited from our parents, and by studying and com-
paring our genotypes and traits with the genotypes and traits of other related
and unrelated indiviuals we can identify which genotypes give rise to different
phenotypes.
A parameter which is often used to describe genetic models for (binary)
traits is penetrance, the probability of a particular phenotype F for a given
genotype Gi,
fi = P (F |Gi).
There are several genetic models, a mendelian trait is determined by one gene,
for a dominant trait it is enough for one of the two alleles at the loci to be of the
susceptible type for the trait to be expressed in the organism, and for a recessive
trait both of the alleles need to be of this type. For completely dominant and
recessive traits penetrances are either 0 or 1. There are also incomplete pen-
etrance models, where some of the penetrance parameters are below 1, hence
the trait is expressed in some, but not all, of the individuals with that genotype.
If there are phenocopies f > 0 for subjects who do not carry the risk allele
(explained by risk variants at other loci or only environmental factors).
A mendelian trait has a clear relation between the causative gene and the
phenotype. There are also many non-mendelian traits such as polygenic or
complex traits and sex-linked traits.
Complex traits which are the subject of this thesis, are traits where typically
several genes and environmental factors are involved. These traits or disorders
are often common in the population and have various expressions in the affected
individuals. Each involved gene commonly has a subtle marginal effect, and it
is therefore hard to identify.
2.1.2 Genetic Association
It has been very useful to map disease genes using neutral markers and thereby
identify spots where segregation pattern of disease and markers coincide, this
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is done using Linkage Analysis with samples from families with multiple cases.
Many of the mendelian disorders have been successfully analyzed using this
method. But Linkage analysis does not perform as well in Complex diseases
[4].
Consider two loci M with alleles M1 and M2, and D with alleles D1 and
D2, if the alleles M1 and D1 are associated with each other in a non-random
manner, that is P (MiDj) 6= P (Mi)P (Dj), because of close physical positions
on the same chromosome (and recombination between the loci is rare), they are
said to be in Linkage Disequilibrium (LD). This property can be used to search
for genes associated with some disease. If a studied locus is close to the locus
of the causal gene, it is likely that the marker alleleM1 is in LD with the disease
allele D1, and M1 will tend to be inherited together with the disease gene.
With a dense set of markers distributed across parts of or the entire genome
it is possible to perform Association studies. A genetic locus is associated with
a trait if different genotypes at the locus have different distributions for the trait,
e.g. if individuals with one genotype tend to be taller than other individuals,
then this locus could be associated with human height, or if it is a binary trait
like CD the proportion of affected will differ between the genotypes. For a
binary trait this can also be expressed as different frequencies among affected
and healthy individuals. As the genotyping technology has improved it has
become possible to obtain data from a much larger sets of markers, improving
the precision in the association signals.
Association studies do not require family samples, but can also be per-
formed with samples consisting of unrelated cases and controls. When per-
formed in case-control studies associated regions are identified by comparing
allele or genotype frequencies among the cases and controls. Case-control stud-
ies have the advantages that it is often easier to recruit cases and controls com-
pared to entire families, and controls can often be re-used in several studies.
But families are still useful in association studies, by comparing how frequently
each of the alleles from a heterozygous parent is transmitted to the offspring.
Family studies has the advantage that they are more robust agains population
substructures than case-control studies [5].
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The markers which are used to find these associated genes are generally
positions which vary between individuals, but where the genetic variation is
not associated with any traits. The markers used in Genome Wide Associa-
tion Studies (GWAS) are Single Nucleotide Polymorphisms (SNPs). SNPs are
variations in the genome where one single nucleotide has been substituted to
another, without affecting the neighbouring nucleotides. E.g. if a C nucleotide
have been substituted with a T in some individuals, then that locus is a SNP
with alleles C and T.
The genotyping chips which are used in GWAS are designed such that the
chosen SNPs are distributed evenly across the genome in a way that they shall
be able to detect most of the common genetic risk variants. This design is
based on the assumption of Common Disease, Common Variant [6], which says
that for several common diseases, most of the genetic risk can be explained by
variants with allele frequency about 1-5 % with a (marginally) modest effect on
the increased risk of the disease.
2.1.3 Missing heritability
In many complex diseases there are many genetic variants which have been
identified. But for many of the recent studies these common variants only ex-
plain a small fraction of the increased risk. This suggests that the hypothesis
of ’Common disease, common variant’ is not as valid as was previously be-
lieved. [7]
Possible explanations include that part of the increased risk can be explained
by many rare variants, which are present among less than 1 % of the population.
This suggests that there could be heterogenetiy, where different genetic profiles
can cause diseases that are diagnostically the same. Other explanations could be
some kind of interaction between different genes which could be hard to detect
when analyzing one SNP at the time. Such interactions could be epistasis,
where the effect of one gene is affected by other genes.
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2.2 Genetic Interactions
To detect interactions we need to define how a ’natural’ combined effect of two
risk loci would be expressed in the organism. The concept of gene-gene inter-
actions is not new, but still it is confusing since the term is used in various ways.
Biological interaction or epistasis was defined first by Bateson in 1909 [8]. In
that example one of the alleles at one locus G is preventing the alleles at lo-
cus B from being expressed in the organism. This relation does not necessarily
have to be symmetric. This definition is similar to the definition biologists use
to examine a biological interaction between proteins, where proteins interact to
regulate several cellular processes.
In statistics the definition of interaction is usually a deviation from a linear
model. In 1918 Fisher made a statistical definition of epistasis [9], as deviation
from additivity in effects of the alleles at different loci on a quantitative trait.
This definition is more similar to the classical statistical definition of interaction
and do not quite correspond to the biological definition of epistasis.
These definitions get troublesome when the trait is binary, in these cases the
mathematical modelling often focus on the penetrances, hence the definitions
of epistasis need to be modified. For binary traits an example could be that
both allele A and allele B at two different loci are needed to develop the trait.
In this case A is epistatic to B, and B is epistatic to A, hence the epistasis is
symmetric - in contrast to the definition by Bateson. A classic way to represent
lack of epistasis has been the heterogeneity model [10] - a person gets the trait by
possessing (at least) one of the predisposing genotypes. This definition actually
falls under Bateson’s definition of epistasis, for example if a person has both
risk variants (situated at different loci) the effect of allele A will be masked
by allele B - another confusing issue about these genetic interactions. There
are two types of genetic heterogeneity, allelic heterogeneity is when several
mutations on the same allele cause the same disease. Locus heterogeneity means
that mutations in several unrelated loci can cause the same disorder. The above
example of locus heterogenetity could be generalized to a situation without full
penetrance, that is 0 < fi,j < 1 for some of the penetrances. Mathematically,
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locus heterogeneity can be expressed as
fij = αi + βj − αiβj ,
where αi and βj are the penetrance factors for the two genetic variants [11].
Locus heterogeneity is similar to a daisy chain, where it is enough for one of
the components to break for the entire system to malfunction, i.e. to obtain the
disease. There are two other common two-locus models for binary traits, the
multiplicative model,
fij = αiβj ,
this model is often considered as epistatic, and we also have the additive model
fij = αi + βj ,
both the heterogeneity and the additive model is thought of as non-epistatic.
There is an interesting relationship between a heterogeneity disease model and
a multiplicative models.
A heterogeneity disease model is equivalent to a multiplicative health model.
In the heterogeneity model you get affected if you have at least one of the risk
variants, hence you stay unaffected if you have the ’protective alleles’ at both
loci.
Further problems appear when considering that both the multiplicative and
the heterogeneity models become additive with suitable log transformations,
such as logistic regression, which is a popular method among epidemiologists.
If the underlying model is heterogeneity logistic regression will interpret it as
interaction.
The main issue in finding interactions, independent of how you define epis-
tasis, is how you should detect it in complex diseases when analyzing millions
of genetic markers. If the disease is caused by different mutations on differ-
ent loci in various families, and these genes have a strong effect in each of the
subpopulations, the heterogenetic risk genes will probably show a very weak
marginal effect when the markers are analyzed one at the time. For epistatic
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interactions it will be very computationally demanding to examine all possible
gene-gene interactions, in additition to the issue of correcting for testing multi-
ple hypotheses. One way to handle this is to first test for marginal main effects
for each marker in the sample, and hope that the genes involved in interactions
will also show at least a modest marginal effect. Then the results from this anal-
ysis is combined with biological knowledge to suggest a number of candidates
for interaction analysis.
2.3 Imputation of genotypes
During the last few years, collaborations like the International Hapmap Project
and the 1,000 Genomes Project have enabled a large catalog of the human ge-
netic variation, which is growing for each month still. When researchers collect
several data sets using SNP arrays from platforms with different sets of SNP
markers, some markers will only be genotyped in parts of the study material.
Using effective imputation algorithms, we can predict or impute genotypes
at these markers and thereby increase the sample size at these loci and the power
of the association analysis. The imputation algorithms are based on known
genotypes at typed markers and information about LD between markers from
a reference sample [12], that have been genotyped on a much more dense set
of markers, which is used to predict the genotypes of markers which were not
observed in (parts of) the study sample.
The sets of SNPs used in most SNP arrays are chosen in a way that that they
should efficiently capture most common variations across the genome, this is
well suited for imputation, compared to random selection of markers. But the
genotyping platforms often differ in their marker sets, hence imputation is an
important tool to merge studies genotyped on different platforms.
HapMap provides references datasets for several human populations, and
there are several softwares for imputation, which use varying algorithms, some
of the most common are Mach, Beagle, Impute and Plink [12–16].
Most of the algorithms are based on Hidden Markov Models and Markov
Chain Monte Carlo [14] methods and they provide posterior probabilities for
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each of the three possible genotypes at each locus, cutoffs can then be applied
to impute the most confident genotypes.
One issue that makes this imputation troublesome is that the different providers
of SNP arrays use different strands when reading the alleles at the markers. This
implies that, when allele A is observed at a specific locus using one platform, the
complementary allele T would be observed with some other platform. Hence
we need to flip the alleles at loci where the possible alleles in the study mate-
rial is different from the reference sample. This gets even more difficult at loci
where the possible alleles are A and T (or C and G), then it is not possible to
directly spot if the alleles are read on the same strands or not, in the two mate-
rials. Hence a ’strand translation’ code is needed to flip the alleles which need
to be flipped in the study sample before the imputation can be performed. If
this information is not directly provided from the genotyping platform it also is
time consuming to sort this out by comparing the alleles in different data sets.
Association tests for imputed markers should be similar to test signals for
other markers on surrounding loci, hence it is important to be cautious with
checking if an imputed marker has a very different association signal compared
to the surrounding markers.
2.4 Statistical methods in GWAS
If a genetic marker is associated to a particular disease, then the genotype or
allele frequencies will be different among cases and controls. A commonly used
test for searching for associated SNPs in case-control studies is a Pearson χ21 test
applied to a 2-by-2 table of allele counts in the two groups. In complex traits
it is commonly assumed that the contribution to the genetic effect from each
SNP is roughly additive [17]. This test is powerful for additive models, where
the penetrance for heterozygous are somewhere in between the penetrance for
the two homozygotes, whereof the popularity of this test in these studies. Other
common tests include a Pearson χ2 test comparing the genotype frequencies
instead of alleles, Cochran Armitage test for trend in penetrances and logistic
regression.
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The Transmission Disequilibrium Test (TDT) is an association test using
data from families with at least one affected child, evaluating the transmission of
an allele from a heterozygous parent to the offspring. This test was introduced
by Spielman et al. [18]. It is based on the assumption that each of the two alleles
M1 and M2 at a locus is transmitted with equal probability to the offspring,
hence for a sample of heteroxygous parents we expect approximately half of
them to transmit the allele M1. If one of the alleles is transmitted more often
among families where the children has a genetic disease, we suspect that the
allele is associated to the disease. The test statistic has the following form
T =
(b− c)2
b+ c
, (2.1)
where b is the number of heterozygous parents who transmits allele M1 to their
offspring, and c is the number of heterozygous parents who transmits allele
M2. This test, which is sometimes called ”McNemar Test”, is equivalent to a
Pearson χ2-test,∑ (O − E)2
E
,
with E = (b + c)/2 and follows a χ21-distribution. Let bk and ck be the cor-
responding counts for each trio - father, mother and affected offspring - then
b =
∑K
k=1 bk, c =
∑K
k=1 ck and K is the number of trios.
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Chapter 3
Summary of Papers
3.1 Paper I
A common test in Genome Wide case-control associaton studies is the Pearson
χ21-test comparing allele frequencies among the two groups.
In coeliac disease a genetic variant in the HLA-region on chromosome 6 in
the human genome is necessary but not sufficient for developing the disease.
As this variant also is present in healthy individuals, other risk variants should
be less common among the controls who possess the necessary gene, compared
to the controls who lacks this variant. Similarly, the same allele should be more
common among the cases. Hence we have refined the alternative hypothesis to
H1 : pctrl+A < p
ctrl−
A < p
case
A ,
where P ∗A denotes the frequency of the risk increasing allele A in each of the
three subpopulations. ctrl+ denotes the population of individuals who has the
necessary genetic component, denoted by H, but is not affected by the studied
disease. Similarly, ctrl− consist of all individuals who do not have the gene H,
and finally the cases. In the paper we derive a test that can examine this kind of
genetic model.
A test for trends in proportions is the Cochran-Armitage test [19]. This test
17
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needs a parameter ρ describing the relative differences between the proportions,
that is
ρ =
pctrl−A − pctrl+A
pcaseA − pctrl+A
. (3.1)
We show that ρ = P (aff|H), hence we estimate ρ by the disease prevalence
among the individuals who has the necessary gene H. This entity is thus inde-
pendent of the marginal model for any other gene that we are searching for.
We use simulations from various genetic models of this type to estimate the
power of this test compared with the Pearson 1 df chi-square test. We also apply
this method to a previously published [20] celiac disease case-control study and
compare the result on genes which was replicated in further studies.
3.2 Paper II
In this applied paper we run a GWAS on a family material in Coeliac Disease.
Since the the material was genotyped using two different platforms we use im-
puted genotypes to increase the sample size at genetic markers that was not
observed in all subjects of the sample.
The first analysis is performed with the Transmission Disequilibrium test
(TDT) defined in (2.1). The imputation algorithm do not account for the family
structure of the sample, hence we will obtain positive probabilities for impossi-
ble combinations of genotypes in a family. For a biallelic marker, there are 15
possible trio combinations,we denote these by
τi = {Fi,Mi, Ci}, i = 1, . . . 15,
where Fi,Mi and Ci denotes the genotypes of the members in the trio τi. Let
k denote the studied trio with posterior probabilities PF,k, PM,k and PC,k The
probability for each of these can be calculated from the imputation probabilities
as
PTk (τi) = PF,k(Fi)PM,k(Mi)PC,k(Ci). (3.2)
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If the imputation resulted in impossible trios,
∑
i P
T
k (τI) < 1, we then normal-
ize this posterior distribution by
P ∗k (τi) =
{
PTk (τi)P15
i=1 P
T
k (τi)
if
∑15
i=1 P
T
k (τi) > c,
0 otherwise,
(3.3)
for some threshold c. Based on this posterion distribution P ∗k we calculate the
expected counts bk and ck in each trio k,
EP∗k [bk] =
15∑
i=1
b(τi)P ∗k (τi), EP∗k [ck] =
15∑
i=1
c(τi)P ∗k (τi),
The expected counts will then replace the observed counts in (2.1) which then
get the following form,
Timp =
(∑
k EP∗k [bk − ck]
)2∑
k EP∗k [bk + ck]
(3.4)
and the test statistic follows the χ21 distribution, like the standard TDT.
This method is applied to the the CD material with c = 0.7, as well as the
standard TDT with a threshold of 0.95 for the imputation probabilities.
A two-locus interaction analysis based on the test in [21] was performed
comparing the heterogeneity model with the full model (epistasis) using a like-
lihood ratio test with 4 degrees of freedom. The likelihood of the penetrances
and allele frequencies,
L(f, pA, pB) =
∏
i,j
(
fijP (AiBj)∑
k,l fklP (AkBl)
)nij
P (AiBj)mij ,
where P (AiBj) = hij(pA, pB). will not have a unique solution to the max-
imization problem if we do not fix the disease prevalence
∑
k,l fklP (AkBl).
The likelihood maximization is performed numerically using the software R.
This method was applied to the CD material, with one affected child from
each family, on a set of genetic markers which was chosen based on the TDT
analysis and previous results.
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